Sodium aurothiomalate
From Wikipedia, the free encyclopedia
| Image:Sodium aurothiomalate.png | |
|
Sodium aurothiomalate
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | M01CB02 |
| PubChem | 4479093 |
| Chemical data | |
| Formula | C4H3AuNaO4S |
| Mol. weight | 344.097 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 0% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
POM(UK) |
| Routes | intramuscular injection |
Sodium aurothiomalate (gold sodium thiomalate) is an organogold compound used for its antirheumatic effects to treat rheumatoid arthritis. In the United Kingdom only this intramuscular injection drug and the orally taken Auranofin are used medically.
[edit] See also
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
